|
US4298602A
(en)
|
1978-10-13 |
1981-11-03 |
The Dow Chemical Company |
Heterocyclic substituted triazolyl phosphorous compounds and their use as insecticides
|
|
DE3737748A1
(de)
|
1987-11-03 |
1989-05-18 |
Schering Ag |
3-arylsulfonylamino-1h-1,2,4-triazole, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider und wachstumsregulierender wirkung
|
|
DE3905714A1
(de)
|
1989-02-24 |
1990-09-06 |
Bayer Ag |
Sulfonylimino-azinylheteroazole, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als herbizide
|
|
DE3928605A1
(de)
|
1989-08-30 |
1991-03-07 |
Bayer Ag |
Substituierte sulfonylaminoazole
|
|
GB8929022D0
(en)
|
1989-12-22 |
1990-02-28 |
Ici Plc |
Diazine derivatives
|
|
JPH04348326A
(ja)
|
1990-07-09 |
1992-12-03 |
Sumitomo Electric Ind Ltd |
有機非線形光学材料
|
|
DE4124942A1
(de)
|
1991-07-27 |
1993-01-28 |
Thomae Gmbh Dr K |
5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
JP3264492B2
(ja)
|
1992-01-13 |
2002-03-11 |
スミスクライン・ビーチャム・コーポレイション |
ピリジル置換イミダゾール
|
|
WO1993022311A1
(en)
|
1992-04-27 |
1993-11-11 |
E.I. Du Pont De Nemours And Company |
Fungicidal 1,3,4-oxadiazines and 1,3,4-thiadiazines
|
|
JPH06220059A
(ja)
|
1993-01-28 |
1994-08-09 |
Tanabe Seiyaku Co Ltd |
縮合ピリミジン誘導体及びその製法
|
|
DE4427529A1
(de)
|
1994-08-04 |
1996-02-08 |
Bayer Ag |
Verfahren zur Herstellung von 1,2,4-Triazin-3,5-dionen
|
|
SK72996A3
(en)
|
1995-06-07 |
1997-04-09 |
Pfizer |
Heterocyclic ring-fused pyrimidine derivatives and pharmaceutical compositions on their base
|
|
DE19536891A1
(de)
|
1995-10-04 |
1997-04-10 |
Basf Ag |
Neue Aminosäurederivate, ihre Herstellung und Verwendung
|
|
ZA973884B
(en)
|
1996-05-23 |
1998-11-06 |
Du Pont Merck Pharma |
Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
|
|
KR20000057228A
(ko)
|
1996-11-27 |
2000-09-15 |
디. 제이. 우드, 스피겔 알렌 제이 |
축합된 비사이클릭 피리미딘 유도체
|
|
JPH10251255A
(ja)
|
1997-03-14 |
1998-09-22 |
Nissan Chem Ind Ltd |
アジン誘導体
|
|
JP2000086663A
(ja)
|
1998-09-09 |
2000-03-28 |
Taisho Pharmaceut Co Ltd |
アリールテトラヒドロピリジン誘導体
|
|
EP1396489A1
(en)
|
1999-01-27 |
2004-03-10 |
Pfizer Products Inc. |
Heteroaromatic bicyclic derivatives useful as anticancer agents
|
|
US7122666B2
(en)
|
1999-07-21 |
2006-10-17 |
Sankyo Company, Limited |
Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
|
|
JP2003104971A
(ja)
|
1999-08-12 |
2003-04-09 |
Wakunaga Pharmaceut Co Ltd |
新規アニリド誘導体又はその塩及びこれを含有する医薬
|
|
WO2001030778A1
(en)
|
1999-10-27 |
2001-05-03 |
Novartis Ag |
Thiazole and imidazo [4,5-b] pyridine compounds and their pharmaceutical use
|
|
CA2396693A1
(en)
|
1999-12-28 |
2001-07-05 |
Stephen T. Wrobleski |
Cytokine, especially tnf-alpha, inhibitors
|
|
ATE372337T1
(de)
|
2000-02-01 |
2007-09-15 |
Abbott Gmbh & Co Kg |
Heterozyklische verbindungen und deren anwendung als parp-inhibitoren
|
|
AU2001294557A1
(en)
|
2000-09-11 |
2002-03-26 |
Merck And Co., Inc. |
Thrombin inhibitors
|
|
JP2002284779A
(ja)
|
2001-01-18 |
2002-10-03 |
Sankyo Co Ltd |
ヘテロアリール置換ピロール誘導体を含有する医薬
|
|
DE10108480A1
(de)
|
2001-02-22 |
2002-09-05 |
Bayer Ag |
Pyrazolylpyrimidine
|
|
US6958340B2
(en)
|
2001-08-01 |
2005-10-25 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
US20030191121A1
(en)
|
2001-08-09 |
2003-10-09 |
Miller Ross A. |
Piperazine carboxamide intermediates of HIV protease inhibitors and processes for their preparation
|
|
GB0127929D0
(en)
|
2001-11-21 |
2002-01-16 |
Celltech R&D Ltd |
Chemical compounds
|
|
AU2003203148A1
(en)
|
2002-02-05 |
2003-09-02 |
High Point Pharmaceuticals, Llc |
Novel aryl- and heteroarylpiperazines
|
|
WO2003075828A2
(en)
|
2002-03-11 |
2003-09-18 |
Zetiq Technologies Ltd. |
Compounds useful in the treatment of cancer
|
|
JP2005534632A
(ja)
|
2002-05-10 |
2005-11-17 |
ニューロクライン バイオサイエンセズ， インコーポレイテッド |
メラノコルチンレセプターリガンドとしての置換ピペラジン
|
|
GB0212785D0
(en)
|
2002-05-31 |
2002-07-10 |
Glaxo Group Ltd |
Compounds
|
|
SE0201980D0
(sv)
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
|
WO2004014384A2
(en)
|
2002-08-13 |
2004-02-19 |
Warner-Lambert Company Llc |
Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors
|
|
MXPA05004607A
(es)
|
2002-10-30 |
2005-06-08 |
Ciba Sc Holding Ag |
Dispositivo electroluminiscente.
|
|
US7223870B2
(en)
|
2002-11-01 |
2007-05-29 |
Pfizer Inc. |
Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
|
|
US20040097492A1
(en)
|
2002-11-01 |
2004-05-20 |
Pratt John K |
Anti-infective agents
|
|
AU2003269399A1
(en)
|
2002-11-01 |
2004-05-25 |
Pfizer Products Inc. |
Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination
|
|
SE0203712D0
(sv)
|
2002-12-13 |
2002-12-13 |
Astrazeneca Ab |
Novel compounds
|
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
|
US7569591B2
(en)
|
2003-01-31 |
2009-08-04 |
Vertex Pharmaceuticals Incorporated |
Gyrase inhibitors and uses thereof
|
|
US7078419B2
(en)
|
2003-03-10 |
2006-07-18 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Cytokine inhibitors
|
|
US7122557B2
(en)
|
2003-03-18 |
2006-10-17 |
Bristol-Myers Squibb Company |
Sulfonyl-amidino-containing and tetrahydropyrimidino-containing compounds as factor Xa inhibitors
|
|
GB0306329D0
(en)
|
2003-03-19 |
2003-04-23 |
Glaxo Group Ltd |
Compounds
|
|
US7244739B2
(en)
|
2003-05-14 |
2007-07-17 |
Torreypines Therapeutics, Inc. |
Compounds and uses thereof in modulating amyloid beta
|
|
DE10322469A1
(de)
|
2003-05-19 |
2004-12-16 |
Bayer Healthcare Ag |
Heterocyclische Verbindungen
|
|
CA2540828A1
(en)
|
2003-09-30 |
2005-04-14 |
Scios Inc. |
Heterocyclic amides and sulfonamides
|
|
DE602004032276D1
(de)
|
2003-10-01 |
2011-05-26 |
Xention Ltd |
Tetrahydro-Naphthalen und Harnstoffderivate
|
|
US20050124623A1
(en)
|
2003-11-26 |
2005-06-09 |
Bender John A. |
Diazaindole-dicarbonyl-piperazinyl antiviral agents
|
|
US20050261497A1
(en)
|
2004-01-02 |
2005-11-24 |
Yuhei Yamamoto |
Catalytic asymmetric hetero diels-alder reaction of a heteroaromatic C-nitroso dienophile: a novel method for synthesis of chiral non-racemic amino alcohols
|
|
US20050165029A1
(en)
|
2004-01-13 |
2005-07-28 |
Ambit Biosciences Corporation |
Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
|
|
AU2005212092B2
(en)
|
2004-02-13 |
2011-01-20 |
Msd K.K. |
Fused-ring 4-oxopyrimidine derivative
|
|
AU2005219438B2
(en)
|
2004-03-03 |
2011-02-17 |
Chemocentryx, Inc. |
Bicyclic and bridged nitrogen heterocycles
|
|
AU2005249380C1
(en)
|
2004-04-23 |
2012-09-20 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
|
JP2007535553A
(ja)
|
2004-04-29 |
2007-12-06 |
アボット・ラボラトリーズ |
アミノ−テトラゾール類縁体および使用方法
|
|
WO2005108387A2
(en)
|
2004-05-03 |
2005-11-17 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Cytokine inhibitors
|
|
FR2870541B1
(fr)
|
2004-05-18 |
2006-07-14 |
Proskelia Sas |
Derives de pyrimidines antigonistes du recepteur de la vitronectine
|
|
SE0401342D0
(sv)
|
2004-05-25 |
2004-05-25 |
Astrazeneca Ab |
Therapeutic compounds
|
|
MXPA06014129A
(es)
|
2004-06-04 |
2007-03-07 |
Arena Pharm Inc |
Derivados de arilo y heteroarilo sustituidos como moduladores del metabolismo y profilaxis y tratamiento de trastornos relacionados con los mismos.
|
|
MY144903A
(en)
|
2004-06-17 |
2011-11-30 |
Novartis Ag |
Pyrrolopyridine derivatives and their use as crth2 antagonists
|
|
AP2006003849A0
(en)
|
2004-06-28 |
2006-12-31 |
Incyte Corp |
3-Aminocyclopentanecarboxamides as modulators of chemokine receptors
|
|
EP1763347A4
(en)
|
2004-06-28 |
2009-05-20 |
Incyte Corp |
3-AMINOCYCLOPENTANECARBOXAMIDES AS MODULATORS OF CHEMOKINE RECEPTORS
|
|
KR20070064356A
(ko)
|
2004-09-29 |
2007-06-20 |
포톨라 파마슈티컬스, 인코포레이티드 |
치환된 2ｈ-1,3-벤족사진-4(3ｈ)온
|
|
WO2006045828A1
(en)
|
2004-10-29 |
2006-05-04 |
Tibotec Pharmaceuticals Ltd. |
Hiv inhibiting bicyclic pyrimidine derivatives
|
|
WO2006074057A2
(en)
|
2004-12-30 |
2006-07-13 |
Exelixis, Inc. |
Pyrimidine derivatives as kinase modulators and method of use
|
|
US7652041B2
(en)
|
2005-01-14 |
2010-01-26 |
Millennium Pharmaceuticals, Inc. |
Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity
|
|
BRPI0607739A2
(pt)
|
2005-02-25 |
2009-09-29 |
Serenex Inc |
derivados de tetraidroindolona e tetraidroindazolona, composição compreendendo os mesmos e uso relacionado
|
|
US7470693B2
(en)
|
2005-04-21 |
2008-12-30 |
Bristol-Myers Squibb Company |
Oxalamide derivatives as kinase inhibitors
|
|
US7931909B2
(en)
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
|
DE102005023943A1
(de)
|
2005-05-20 |
2006-11-23 |
Grünenthal GmbH |
Pentafluorsulfanyl-substituierte Verbindung und deren Verwendung zur Herstellung von Arzneimitteln
|
|
WO2006138304A2
(en)
|
2005-06-14 |
2006-12-28 |
Taigen Biotechnology |
Pyrimidine compounds
|
|
US8193206B2
(en)
|
2005-06-14 |
2012-06-05 |
Taigen Biotechnology Co., Ltd. |
Pyrimidine compounds
|
|
FR2889189A1
(fr)
|
2005-07-28 |
2007-02-02 |
Cerep Sa |
Composes derives d'hydantoine et leur utilistion en tant qu'antagonistes de mchr-1
|
|
WO2007021941A2
(en)
|
2005-08-16 |
2007-02-22 |
Icagen, Inc. |
Inhibitors of voltage-gated sodium channels
|
|
WO2007030574A2
(en)
|
2005-09-07 |
2007-03-15 |
Plexxikon, Inc. |
1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds
|
|
JP4531027B2
(ja)
|
2005-09-29 |
2010-08-25 |
田辺三菱製薬株式会社 |
医薬組成物
|
|
JP2007126551A
(ja)
|
2005-11-02 |
2007-05-24 |
Fujifilm Corp |
蛍光性重合体微粒子、蛍光検出キット及び蛍光検出方法
|
|
GB0525337D0
(en)
|
2005-12-13 |
2006-01-18 |
Novartis Ag |
Organic compounds
|
|
US7465795B2
(en)
|
2005-12-20 |
2008-12-16 |
Astrazeneca Ab |
Compounds and uses thereof
|
|
NL2000323C2
(nl)
|
2005-12-20 |
2007-11-20 |
Pfizer Ltd |
Pyrimidine-derivaten.
|
|
MEP1008A
(xx)
|
2005-12-21 |
2010-02-10 |
Incyte Corp |
3-aminociklopentankarboksamidi kao modulatori receptora hemokina
|
|
KR20080083188A
(ko)
|
2006-01-11 |
2008-09-16 |
아스트라제네카 아베 |
모르폴리노 피리미딘 유도체 및 요법에서의 그 유도체의용도
|
|
JP2007186580A
(ja)
|
2006-01-12 |
2007-07-26 |
Fujifilm Corp |
重合体粒子、蛍光性重合体微粒子、重合体微粒子の製造方法、蛍光性重合体微粒子の製造方法、蛍光検出キット及び蛍光検出方法
|
|
UY30117A1
(es)
|
2006-01-31 |
2007-06-29 |
Tanabe Seiyaku Co |
Compuesto amina trisustituido
|
|
FR2897061B1
(fr)
|
2006-02-03 |
2010-09-03 |
Sanofi Aventis |
Derives de n-heteroaryl-carboxamides tricycliques contenant un motif benzimidazole, leur preparation et leur application en therapeutique.
|
|
ATE470665T1
(de)
|
2006-03-22 |
2010-06-15 |
Janssen Pharmaceutica Nv |
Cycloalkylaminderivate als inhibitoren der wechselwirkung zwischen mdm2 und p53
|
|
DOP2007000068A
(es)
|
2006-04-12 |
2007-10-31 |
Sanofi Aventis Us Llc |
Compuestos de amino-pirimidina 2,6-sustituidos-4-monosustituidos como antagonistas del receptor de prostaglandina d2
|
|
WO2008005368A2
(en)
|
2006-06-30 |
2008-01-10 |
Abbott Laboratories |
Piperazines as p2x7 antagonists
|
|
EP2043651A2
(en)
|
2006-07-05 |
2009-04-08 |
Exelixis, Inc. |
Methods of using igf1r and abl kinase modulators
|
|
US20080021063A1
(en)
|
2006-07-18 |
2008-01-24 |
Kazantsev Aleksey G |
Compositions and methods for modulating sirtuin activity
|
|
AU2007287428B2
(en)
|
2006-08-24 |
2011-08-11 |
Astrazeneca Ab |
Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
|
|
EP2057129A1
(en)
|
2006-08-24 |
2009-05-13 |
AstraZeneca AB |
Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
|
|
JP4776473B2
(ja)
|
2006-08-25 |
2011-09-21 |
株式会社ミツトヨ |
光軸偏向型レーザ干渉計、その校正方法、補正方法、及び、測定方法
|
|
JP2008074892A
(ja)
|
2006-09-19 |
2008-04-03 |
Fujifilm Corp |
蛍光性重合体微粒子セット、蛍光検出用複合体セット、蛍光性重合体微粒子組成物及び蛍光検出方法
|
|
GB0625196D0
(en)
|
2006-12-18 |
2007-01-24 |
7Tm Pharma As |
Modulators of cannabinoid receptor
|
|
NZ577798A
(en)
*
|
2006-12-21 |
2012-04-27 |
Vertex Pharma |
5-cyano-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
|
|
US8338437B2
(en)
|
2007-02-28 |
2012-12-25 |
Methylgene Inc. |
Amines as small molecule inhibitors
|
|
JP2010522194A
(ja)
|
2007-03-20 |
2010-07-01 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
キナーゼ阻害薬として有用なアミノピリミジン
|
|
EP2014657A1
(de)
|
2007-06-21 |
2009-01-14 |
Bayer Schering Pharma Aktiengesellschaft |
Diaminopyrimidine als Modulatoren des EP2-Rezeptors
|
|
CA2692720A1
(en)
|
2007-07-09 |
2009-01-15 |
Astrazeneca Ab |
Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k
|
|
EA201000092A1
(ru)
|
2007-07-09 |
2010-06-30 |
Астразенека Аб |
Тризамещенные пиримидиновые производные для лечения пролиферативных заболеваний
|
|
EP2178866A2
(en)
|
2007-07-09 |
2010-04-28 |
AstraZeneca AB |
Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
|
|
AU2008273892A1
(en)
|
2007-07-09 |
2009-01-15 |
Astrazeneca Ab |
Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
|
|
WO2009011627A1
(en)
|
2007-07-13 |
2009-01-22 |
Astrazeneca Ab |
Pyridine compounds and their use as p2y12 antagonists
|
|
WO2009017671A1
(en)
|
2007-07-26 |
2009-02-05 |
Vitae Pharmaceuticals, Inc. |
Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
|
|
JP2011500727A
(ja)
|
2007-10-22 |
2011-01-06 |
シェーリング コーポレイション |
Ｇｐｒ１１９の活性のモジュレーターとしての二環式ヘテロ環誘導体およびその使用
|
|
CA2710016A1
(en)
|
2007-12-21 |
2009-07-02 |
The University Of Sydney |
Translocator protein ligands
|
|
AU2008345225A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
FR2926556B1
(fr)
|
2008-01-22 |
2010-02-19 |
Sanofi Aventis |
Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique
|
|
CN101965177A
(zh)
|
2008-02-08 |
2011-02-02 |
株式会社资生堂 |
美白剂和皮肤外用剂
|
|
BRPI0907155B8
(pt)
|
2008-02-12 |
2022-06-28 |
Dow Agrosciences Llc |
Compostos pesticidas, e processos para controlar pestes
|
|
WO2009103432A2
(en)
|
2008-02-21 |
2009-08-27 |
Sanofi-Aventis |
Covalently binding imaging probes
|
|
CA2720049A1
(en)
|
2008-03-31 |
2009-10-08 |
Zenyaku Kogyo Kabushikikaisha |
Pyrimidine derivative having cell protecting effect and uses thereof
|
|
EP2264031B1
(en)
|
2008-04-18 |
2015-04-15 |
Daewoong Pharmaceutical Co., Ltd. |
A novel benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof
|
|
EP2291373B1
(en)
|
2008-05-01 |
2013-09-11 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
EP2296653B1
(en)
|
2008-06-03 |
2016-01-27 |
Intermune, Inc. |
Compounds and methods for treating inflammatory and fibrotic disorders
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
PE20110136A1
(es)
|
2008-06-27 |
2011-03-17 |
Novartis Ag |
Compuestos organicos
|
|
JP2010030970A
(ja)
|
2008-07-31 |
2010-02-12 |
Bayer Cropscience Ag |
殺虫性ベンゼンジカルボキサミド誘導体
|
|
JP5674661B2
(ja)
|
2008-08-20 |
2015-02-25 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
エチニル置換ピリジンおよびピリミジン誘導体ならびにそれらのウイルス感染の治療における使用
|
|
US8697694B2
(en)
|
2008-08-20 |
2014-04-15 |
Merck Sharp & Dohme Corp. |
Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
|
|
AU2009282574B2
(en)
|
2008-08-20 |
2014-08-21 |
Merck Sharp & Dohme Corp. |
Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
|
|
GB0815369D0
(en)
|
2008-08-22 |
2008-10-01 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
|
WO2010036316A1
(en)
|
2008-09-24 |
2010-04-01 |
Yangbo Feng |
Urea and carbamate compounds and analogs as kinase inhibitors
|
|
CA2740366A1
(en)
|
2008-10-21 |
2010-04-29 |
Metabolex, Inc. |
Aryl gpr120 receptor agonists and uses thereof
|
|
GB2465405A
(en)
|
2008-11-10 |
2010-05-19 |
Univ Basel |
Triazine, pyrimidine and pyridine analogues and their use in therapy
|
|
JP2012512252A
(ja)
|
2008-12-17 |
2012-05-31 |
ブイアイエイ・ファーマシューティカルズ・インコーポレーテッド |
ジアシルグリセロールアシルトランスフェラーゼの阻害剤
|
|
EA024252B1
(ru)
|
2009-01-08 |
2016-08-31 |
Кьюрис, Инк. |
Ингибиторы фосфоинозитид-3-киназ с цинксвязывающей группой
|
|
KR101720961B1
(ko)
|
2009-02-27 |
2017-03-29 |
셀룰러 다이내믹스 인터내셔널, 인코포레이티드 |
다능성 세포의 분화
|
|
WO2010100127A1
(en)
|
2009-03-04 |
2010-09-10 |
Novartis Ag |
Disubstituted imidazole derivatives as modulators of raf kinase
|
|
CA2756808A1
(en)
|
2009-03-31 |
2010-10-07 |
Arqule, Inc. |
Substituted indolo-piperidine compounds
|
|
WO2010114957A1
(en)
|
2009-04-03 |
2010-10-07 |
Schering Corporation |
Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders
|
|
WO2010120994A2
(en)
|
2009-04-17 |
2010-10-21 |
Wyeth Llc |
Ureidoaryl-and carbamoylaryl-morpholino- pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesis
|
|
US9186353B2
(en)
|
2009-04-27 |
2015-11-17 |
Abbvie Inc. |
Treatment of osteoarthritis pain
|
|
US9908884B2
(en)
|
2009-05-05 |
2018-03-06 |
Dana-Farber Cancer Institute, Inc. |
EGFR inhibitors and methods of treating disorders
|
|
WO2010135470A1
(en)
|
2009-05-19 |
2010-11-25 |
Intermune, Inc. |
Pifenidone derivatives for treating bronchial asthma
|
|
CN102548411B
(zh)
|
2009-08-07 |
2014-07-02 |
陶氏益农公司 |
杀虫组合物
|
|
US9567318B2
(en)
|
2009-08-17 |
2017-02-14 |
Memorial Sloan-Kettering Cancer Center |
Substituted pyrimidine compounds and uses thereof
|
|
US9029359B2
(en)
|
2009-09-04 |
2015-05-12 |
Biogen Idec Ma, Inc. |
Heteroaryl Btk inhibitors
|
|
HUE043522T2
(hu)
|
2009-09-04 |
2019-08-28 |
Biogen Ma Inc |
Bruton tirozinkináz inhibitorok
|
|
AU2010308306A1
(en)
|
2009-10-19 |
2012-05-10 |
Synta Pharmaceuticals Corp. |
Combination cancer therapy with HSP90 inhibitory compounds
|
|
KR20110049217A
(ko)
|
2009-11-04 |
2011-05-12 |
다우어드밴스드디스플레이머티리얼 유한회사 |
신규한 유기 발광 화합물 및 이를 채용하고 있는 유기 전계 발광 소자
|
|
US8476225B2
(en)
|
2009-12-04 |
2013-07-02 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
SG181811A1
(en)
|
2009-12-18 |
2012-07-30 |
Activesite Pharmaceuticals Inc |
Prodrugs of inhibitors of plasma kallikrein
|
|
WO2011078143A1
(ja)
|
2009-12-22 |
2011-06-30 |
塩野義製薬株式会社 |
ピリミジン誘導体およびそれらを含有する医薬組成物
|
|
DE202011110503U1
(de)
|
2010-01-28 |
2014-12-04 |
The Regents Of The University Of Michigan |
Hängetropfenvorrichtungen und -systeme
|
|
WO2011105572A1
(ja)
|
2010-02-26 |
2011-09-01 |
持田製薬株式会社 |
新規ヘテロアリール誘導体
|
|
RU2012143897A
(ru)
|
2010-03-16 |
2014-04-27 |
Авентис Фармасьютикалз Инк. |
Замещенные пиримидины как антагонисты рецепторов простагландина d2
|
|
US8691810B2
(en)
|
2010-05-12 |
2014-04-08 |
Abbvie Inc. |
Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases
|
|
US8946230B2
(en)
|
2010-05-13 |
2015-02-03 |
Amgen Inc. |
Aryl- and heteroaryl- nitrogen-heterocyclic compounds as PDE10 inhibitors
|
|
WO2011153553A2
(en)
|
2010-06-04 |
2011-12-08 |
The Regents Of The University Of California |
Methods and compositions for kinase inhibition
|
|
EP2604601B1
(en)
*
|
2010-08-10 |
2016-02-24 |
Astellas Pharma Inc. |
Hetero ring compound
|
|
JP5954838B2
(ja)
|
2010-09-14 |
2016-07-20 |
エクセリクシス， インク． |
Ｐｉ３ｋ−デルタの阻害剤ならびにそれらの使用法および製造法
|
|
BR112013006030B1
(pt)
|
2010-09-29 |
2020-03-17 |
Intervet International B.V. |
Composto e sais ou n-óxidos farmaceuticamente aceitáveis, e, uso do composto
|
|
WO2012041872A1
(en)
|
2010-09-29 |
2012-04-05 |
Intervet International B.V. |
N-heteroaryl compounds with cyclic bridging unit for the treatment of parasitic diseases
|
|
WO2012046869A1
(ja)
|
2010-10-08 |
2012-04-12 |
持田製薬株式会社 |
環状アミド誘導体
|
|
DE102010050558A1
(de)
|
2010-11-05 |
2012-05-10 |
Merck Patent Gmbh |
1H-Pyrrolo[2,3-b]pyridinderivate
|
|
EA201390794A1
(ru)
|
2010-11-30 |
2013-11-29 |
Такеда Фармасьютикал Компани Лимитед |
Бициклическое соединение
|
|
JPWO2012074022A1
(ja)
|
2010-12-01 |
2014-05-19 |
旭硝子株式会社 |
イリジウムカチオン錯体および発光組成物
|
|
AU2012211253B2
(en)
|
2011-01-26 |
2016-11-10 |
Board Of Regents Of The University Of Nebraska |
Small molecule RNase inhibitors and methods of use
|
|
CA2827161A1
(en)
|
2011-03-16 |
2012-09-20 |
F. Hoffmann-La Roche Ag |
6,5-heterocyclic propargylic alcohol compounds and uses therefor
|
|
WO2012142308A1
(en)
|
2011-04-13 |
2012-10-18 |
Activesite Pharmaceuticals, Inc. |
Prodrugs of inhibitors of plasma kallikrein
|
|
WO2012147890A1
(ja)
|
2011-04-27 |
2012-11-01 |
持田製薬株式会社 |
新規アゾール誘導体
|
|
EP2716636A4
(en)
|
2011-04-28 |
2014-11-26 |
Mochida Pharm Co Ltd |
CYCLIC AMIDE DERIVATIVE
|
|
JP2014515364A
(ja)
|
2011-05-27 |
2014-06-30 |
プロビオドルグ エージー |
放射能標識グルタミニルシクラーゼ阻害剤
|
|
PH12013502455A1
(en)
|
2011-05-27 |
2014-01-20 |
Achillion Pharmaceuticals Inc |
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
|
|
EP2554544A1
(en)
|
2011-08-01 |
2013-02-06 |
Almirall, S.A. |
Pyridin-2(1h)-one derivatives as jak inhibitors
|
|
WO2013019824A2
(en)
|
2011-08-02 |
2013-02-07 |
Dow Agrosciences Llc |
Pesticidal compositions and processes related thereto
|
|
WO2013022766A1
(en)
|
2011-08-05 |
2013-02-14 |
Flynn Gary A |
Preparation and methods of use for ortho-aryl 5- membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors
|
|
MX2014002810A
(es)
|
2011-09-09 |
2014-09-08 |
Univ New York |
Compuestos amido como moduladores del receptor nuclear huérfanoyt y usos de los mismos.
|
|
EP2763533B1
(en)
|
2011-10-06 |
2021-12-29 |
Merck Sharp & Dohme Corp. |
Triazolyl pde10 inhibitors
|
|
UA111640C2
(uk)
|
2011-11-08 |
2016-05-25 |
Ф. Хоффманн-Ля Рош Аг |
ПОХІДНІ [1,2,3]ТРИАЗОЛО[4,5-d]ПІРИМІДИНУ ЯК АГОНІСТИ КАНАБІНОЇДНОГО РЕЦЕПТОРА 2
|
|
JP6463130B2
(ja)
|
2011-12-16 |
2019-01-30 |
アメリカ合衆国 |
腫瘍転移及び腫瘍形成の予防及び治療のための化合物並びに方法
|
|
CN103159738B
(zh)
|
2011-12-19 |
2016-09-07 |
上海泓博智源医药股份有限公司 |
炔基桥连的杂芳香化合物及其应用
|
|
US9474779B2
(en)
|
2012-01-19 |
2016-10-25 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compositions and their methods of use
|
|
WO2013117649A1
(en)
|
2012-02-10 |
2013-08-15 |
Galapagos Nv |
Imidazo [4, 5 -c] pyridine derivatives useful for the treatment of degenerative and inflammatory diseases
|
|
WO2013134467A1
(en)
|
2012-03-07 |
2013-09-12 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Selective histone deactylase 6 inhibitors
|
|
JP6182593B2
(ja)
|
2012-04-20 |
2017-08-16 |
アドヴィーナス セラピューティクス リミテッド |
置換ヘテロ二環化合物、組成物及び医薬並びにそれらの用途
|
|
CN102786512A
(zh)
|
2012-05-31 |
2012-11-21 |
中国人民解放军军事医学科学院毒物药物研究所 |
N-芳基不饱和稠环叔胺类化合物及其制备方法和抗肿瘤应用
|
|
JP2014078482A
(ja)
|
2012-06-08 |
2014-05-01 |
Fujifilm Corp |
非水電解液二次電池および非水電解液
|
|
CN104540814A
(zh)
|
2012-06-28 |
2015-04-22 |
艾伯维公司 |
氰基胍及其作为抗病毒剂的用途
|
|
US20140018361A1
(en)
|
2012-07-11 |
2014-01-16 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
|
WO2014015936A1
(en)
|
2012-07-23 |
2014-01-30 |
Merck Patent Gmbh |
Ligands and their preparation
|
|
RU2018129432A
(ru)
|
2012-07-24 |
2019-03-14 |
Ниссан Кемикал Индастриз, Лтд. |
Композиция культуральной среды и способ культивирования клетки или ткани с использованием указанной композиции
|
|
WO2014015523A1
(en)
|
2012-07-27 |
2014-01-30 |
Hutchison Medipharma Limited |
Novel heteroaryl and heterocycle compounds, compositions and methods
|
|
JP6276762B2
(ja)
|
2012-08-02 |
2018-02-07 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
キナーゼ阻害剤として活性な置換ピロール類
|
|
WO2014185358A1
(ja)
|
2013-05-14 |
2014-11-20 |
国立大学法人京都大学 |
効率的な心筋細胞の誘導方法
|
|
WO2015033558A1
(ja)
|
2013-09-04 |
2015-03-12 |
株式会社大塚製薬工場 |
多能性幹細胞の調製方法
|
|
CN103588795A
(zh)
|
2013-11-27 |
2014-02-19 |
中国科学院福建物质结构研究所 |
一类离子型一价铜发光配合物及其应用
|
|
KR20160125997A
(ko)
|
2014-02-25 |
2016-11-01 |
주식회사 쿠라레 |
스페로이드 제작용 디바이스, 스페로이드의 회수 방법 및 제조 방법
|
|
SG11201700777VA
(en)
|
2014-08-04 |
2017-02-27 |
Nuevolution As |
Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
|
|
TWI656121B
(zh)
|
2014-08-04 |
2019-04-11 |
德商拜耳製藥公司 |
２－（嗎啉－４－基）－１，７－萘啶
|
|
KR20170117020A
(ko)
|
2014-11-21 |
2017-10-20 |
아카나 테라퓨틱스, 엘티디. |
질병의 치료를 위한 융합된 비시클릭 화합물
|
|
CR20170208A
(es)
|
2014-11-21 |
2017-07-17 |
Merck Sharp & Dohme |
Agonistas parciales del receptor de insulina
|
|
US9695280B2
(en)
|
2015-03-03 |
2017-07-04 |
Ricoh Co., Ltd. |
Methods for solid freeform fabrication
|